Mimpara® - min.medicin.dk – information om medicin

Mimpara® anvendes til behandling af for meget calcium i blodet hos patienter med biskjoldbruskkirtelkræft. Anvendes desuden til patienter, som danner for meget ...

Mimpara: Uses, Side Effects, Benefits/Risks | Drugs.com

Medical information for Mimpara including therapeutic indications, usage and dosage instructions, plus benefits and possible risk factors.

Mimpara® - pro.medicin.dk – information om medicin

Tendens til kramper. Risikofaktorer for forlænget QT-interval: Elektrolytforstyrrelser (hypokaliæmi, hypomagnesiæmi, hypocalcæmi), bradykardi, strukturel ...

Cinacalcet - Wikipedia

Cinacalcet is a drug that acts as a calcimimetic (i.e., it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is ...

Mimpara tablets - Summary of Product Characteristics (SmPC ...

Mimpara tablets - Summary of ... After oral administration of Mimpara, maximum plasma cinacalcet concentration is achieved in approximately 2 to 6 hours.

Mimpara | European Medicines Agency

Mimpara is available as tablets and as granules in capsules, to be taken with food or shortly after a meal. The capsules should not be swallowed whole but should be ...

Mimpara® - Apoteket.dk

Virksomme stoffer. Cinacalcet. Anvendes Mimpara® er et middel med virkning på calciumstofskiftet. Virker. Virker ved at hæmme dannelsen af biskjoldbruskkirtelhormon.

Cinacalcet – Wikipedia

Cinacalcet ist EU-weit seit 2004 unter dem Handelsnamen Mimpara ...

Mimpara Abacus Medicine A/S filmovertrukne tabletter 30 mg

Mimpara virker ved at kontrollere niveauerne af paratyroideahormon (PTH), calcium og fosfor i kroppen. Det bruges til behandling af sygdomme, der skyldes problemer ...

Mimpara - European Drugs Reference Encyclopedia

Summary for the public What is Mimpara? Mimpara is a medicine that contains the active substance cinacalcet. It is available as light green, oval tablets (30, 60 and ...